259 related articles for article (PubMed ID: 23862231)
1. [Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].
Chen DA; Yang XZ; Zhang PH; Li GS; Chang DG
Zhonghua Nan Ke Xue; 2013 Jun; 19(6):527-30. PubMed ID: 23862231
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of IL-8 and IL-6 in prostatic fluid with serum prostate-specific antigen level in patients with benign prostatic hyperplasia complicated by prostatitis].
Ren X; Wu C; Yu Q; Zhu F; Liu P; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):135-9. PubMed ID: 26806754
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between anaphylatoxin C3a and benign prostatic hyperplasia with inflammation].
Xie L; Cheng SL; Li YZ; Liu LR; Han P; Chen N; Wei Q; Zhou Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):642-5. PubMed ID: 22007489
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between interleukin-8 levels in expressed prostatic secretion and expressions of bFGF and Bcl-2 in benign prostatic hyperplasia].
Song W; Li DY; Yuan HC; Gu ZH; Shao JL; Wang X
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(2):104-7. PubMed ID: 26792691
[TBL] [Abstract][Full Text] [Related]
7. [LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].
Huang XH; Qin B; Liang YW; Wu QG; Li CZ; Wei GS; Ji HC; Liang YB; Chen HQ; Guan T
Zhonghua Nan Ke Xue; 2013 Jan; 19(1):35-9. PubMed ID: 23469659
[TBL] [Abstract][Full Text] [Related]
8. Correlations of glucose metabolism, insulin resistance and inflammatory factors with symptom score of patients with benign prostatic hyperplasia.
Zhou B; Wang P; Xu WJ; Li YM; Tong DL; Jiang J; Sun ZY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5077-5081. PubMed ID: 30178825
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
10. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].
Zhang HT; Xu Y; Chang JW; Zhang ZH; Liu RL; Ma BJ
Zhonghua Nan Ke Xue; 2012 Mar; 18(3):208-11. PubMed ID: 22474983
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of interleukin-17 and interleukin-8 in the prostatic tissue of the patients with BPH or BPH with inflammation].
Gao R; Liu QX; Zhou HL; Cao LS; Jiang T; Tang SX; Ding YL
Zhonghua Nan Ke Xue; 2017 Aug; 23(8):697-702. PubMed ID: 29726643
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of benign prostatic hyperplasia complicated by chronic prostatitis].
Chang DG; Li GS; Zhang PH; Wu TL; Mei XF; Cao J; Gao P
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):830-3. PubMed ID: 21171270
[TBL] [Abstract][Full Text] [Related]
14. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
Wu XJ; Yang LY; Zhang XZ
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions.
Hochreiter WW; Nadler RB; Koch AE; Campbell PL; Ludwig M; Weidner W; Schaeffer AJ
Urology; 2000 Dec; 56(6):1025-9. PubMed ID: 11113752
[TBL] [Abstract][Full Text] [Related]
17. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
[TBL] [Abstract][Full Text] [Related]
18. Impacts of histological prostatitis on sexual function and lower urinary tract symptoms in patients with benign prostatic hyperplasia.
Wang GC; Zheng JH; Yang B; Che JP; Yan Y; Geng J; Liu M; Huang JH; Xia SQ; Peng B
Urology; 2013 Nov; 82(5):1094-7. PubMed ID: 23915513
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
20. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
